Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Cumulative transcription factor binding and p300-mediated histone acetylation drive enhancer activation frequency.

Created on 01 Aug 2026

Authors

Valentina Baderna, Guido Barzaghi, Rozemarijn Kleinendorst, Kasit Chatsirisupachai, Laura Moniot-Perron, Colm Doyle, Meike Schopp, Tino Hochepied, Claude Libert, Duncan T Odom, Judith B Zaugg, Arnaud R Krebs

Published in

Nature genetics. Jul 31, 2026. Epub Jul 31, 2026.

Abstract

In eukaryotes, transcription factors (TFs) must continuously compete with nucleosomes to access their binding sites, leading to cell-to-cell variability in chromatin accessibility at regulatory regions. Although critical to understand enhancer function in transcription, the mechanisms that define how frequently an enhancer is active in a cell population remain unclear. Here we used single-molecule footprinting to quantify the frequency at which chromatin is accessible at enhancers in response to TF perturbations and changes in their chromatin environment. We find that, individually, most TFs open chromatin in a small fraction of cells, and that cumulative TF binding controls enhancer activation frequency. Moreover, testing the functionality of hundreds of enhancers when inserted at an ectopic genomic location indicates that p300 activity is required for their full activation. Our data support a model in which enhancer activation frequency depends on the cumulative function of multiple TFs and is modulated by p300 activity.

PMID:
42538372
Bibliographic data and abstract were imported from PubMed on 01 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 23
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement